Analysis of candidate genes for morphine preference quantitative trait locus Mop2

Neuroscience

Volumn 277, Issue , 2014, Pages 403-416

  Doyle, G A ^a   Schwebel, C L ^a   Ruiz, S E ^a   Chou, A D ^a   Lai, A T ^a   Wang, M J ^a   Smith, G G ^a,b   Buono, R J ^c   Berrettini, W H ^a   Ferraro, T N ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Biomedical Sciences Cooper Medical School of Rowan University ^*  (United States)

Author keywords

IYD; Ppp1r14c; Rgs17; Two bottle choice; Vip; opioid receptor

Indexed keywords

DELTA OPIATE RECEPTOR; MORPHINE; PROTEIN IYD; PROTEIN MOP2; PROTEIN OPRM1; PROTEIN PPP1R14C; PROTEIN RGS17; PROTEIN VIP; REGULATOR PROTEIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; ANALGESIC AGENT; NARCOTIC AGENT; QUININE; RGS PROTEIN; RGS17 PROTEIN, MOUSE; RGS17 PROTEIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BASE PAIRING; CHROMOSOME 10; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; IYD GENE; MALE; MOP2 GENE; MORPHINE ADDICTION; MORPHINE PREFERENCE; MOUSE; NONHUMAN; OPRM1 GENE; PPP1R14C GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RGS17 GENE; SELF ADMINISTRATION TEST; TWO BOTTLE CHOICE EXPERIMENT; VIP GENE; ANIMAL; BRAIN; C57BL MOUSE; DBA MOUSE; DECISION MAKING; DRINKING BEHAVIOR; DRUG EFFECTS; DRUG SEEKING BEHAVIOR; METABOLISM; PHYSIOLOGY; QUANTITATIVE TRAIT LOCUS; SPECIES DIFFERENCE; ANIMAL TISSUE; BRAIN REGION; C57BL 6 MOUSE; DBA 2 MOUSE; DRUG PREFERENCE; LYD GENE; PROTEIN EXPRESSION; STRAIN DIFFERENCE;

ANALGESICS, NON-NARCOTIC; ANIMALS; BRAIN; CHOICE BEHAVIOR; DRINKING BEHAVIOR; DRUG-SEEKING BEHAVIOR; GENE EXPRESSION; MICE, INBRED C57BL; MICE, INBRED DBA; MORPHINE; NARCOTICS; QUANTITATIVE TRAIT LOCI; QUININE; RGS PROTEINS; SPECIES SPECIFICITY;

EID: 84907023303     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.07.020     Document Type: Article

References (49)

1. Baumgartner A., Pinna G., Hiedra L., Bauer F., Wolf J., Eravci M., Prengel H., Brödel O., Schmidt G., Meinhold H. Effects of acute administration of ethanol and the mu-opiate agonist etonitazene on thyroid hormone metabolism in rat brain. Psychopharmacology (Berl) 1998, 135:63-69.
2. Belknap J.K. Physical dependence induced by the voluntary consumption of morphine in inbred mice. Pharmacol Biochem Behav 1990, 35:311-315.
3. Belknap J.K., Crabbe J.C., Riggan J., O'Toole L.A. Voluntary consumption of morphine in 15 inbred mouse strains. Psychopharmacology (Berl) 1993, 112:352-358.
4. Belknap J.K., Mogil J.S., Helms M.L., Richards S.P., O'Toole L.A., Bergeson S.E., Buck K.J. Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/6 and DBA/2 strains. Life Sci 1995, 57:PL117-124.
5. Bergeson S.E., Helms M.L., O'Toole L.A., Jarvis M.W., Hain H.S., Mogil J.S., Belknap J.K. Quantitative trait loci influencing morphine antinociception in four mapping populations. Mamm Genome 2001, 12:546-553.
6. Berrettini W.H., Alexander R., Ferraro T.N., Vogel W.H. A study of oral morphine preference in inbred mouse strains. Psychiatr Genet 1994, 4:81-86.
7. Berrettini W.H., Ferraro T.N., Alexander R.C., Buchberg A.M., Vogel W.H. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat Genet 1994, 7:54-58.
8. Blizard D.A., Kotlus B., Frank M.E. Quantitative trait loci associated with short-term intake of sucrose, saccharin and quinine solutions in laboratory mice. Chem Senses 1999, 24(4):373-385.
9. Cunningham C.L., Niehus D.R., Malott D.H., Prather L.K. Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology (Berl) 1992, 107:385-393.
10. Doyle G.A., Sheng X.R., Schwebel C.L., Ferraro T.N., Berrettini W.H., Buono R.J. Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice. Neurosci Res 2006, 55:244-254.
11. Doyle G.A., Furlong P.J., Schwebel C.L., Smith G.G., Lohoff F.W., Buono R.J., Berrettini W.H., Ferraro T.N. Fine mapping of a major QTL influencing morphine preference in C57BL/6 and DBA/2 mice using congenic strains. Neuropsychopharmacology 2008, 33:2801-2809.
12. Drgonova J., Zimonjic D.B., Hall F.S., Uhl G.R. Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus. Neuroscience 2010, 165:882-895.
13. Elmer G.I., Pieper J.O., Hamilton L.R., Wise R.A. Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration. Psychopharmacology (Berl) 2010, 208:309-321.
14. Ferraro T.N., Golden G.T., Smith G.G., Martin J.F., Schwebel C.L., Doyle G.A., Buono R.J., Berrettini W.H. Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains. Neuropsychopharmacology 2005, 30:742-746.
15. 2-methionine-enkephalin in C57 BL/6J and DBA/2J mice. Life Sci 1981, 28:729-736.
16. Garzón J., Rodríguez-Muñoz M., Sánchez-Blázquez P. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter. Neuropharmacology 2005, 48:853-868.
17. Garzón J., Rodríguez-Muñoz M., López-Fando A., Sánchez-Blázquez P. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins. Neuropsychopharmacology 2005, 30:1632-1648.
18. Gaupale T.C., Mathi A.A., Ravikumar A., Bhargava S.Y. Localization and enzyme activity of iodotyrosine dehalogenase 1 during metamorphosis of frog Microhyla ornata. Ann N Y Acad Sci 2009, 1163:402-406.
19. Giros B., Pohl M., Rochelle J.M., Seldin M.F. Chromosomal localization of opioid peptide and receptor genes in the mouse. Life Sci 1995, 56:PL369-375.
20. Goodchild M.A., Brownlee G. The effects of two inhibitors of catecholamine synthesis on the content of noradrenaline and dopamine of the rat brain. Br J Pharmacol 1969, 36:203P-204P.
21. Hendry I.A., Kelleher K.L., Bartlett S.E., Leck K.J., Reynolds A.J., Heydon K., Mellick A., Megirian D., Matthaei K.I. Hypertolerance to morphine in G(z alpha)-deficient mice. Brain Res 2000, 870:10-19.
22. Horowitz G.P., Whitney G., Smith J.C., Stephan F.K. Morphine ingestion: genetic control in mice. Psychopharmacology (Berl) 1977, 52:119-122.
23. Karobath M. Catecholamines and the hydroxylation of tyrosine in synaptosomes isolated from rat brain. Proc Natl Acad Sci U S A 1971, 68:2370-2373.
24. Kest B., Palmese C.A., Hopkins E., Adler M., Juni A., Mogil J.S. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Neuroscience 2002, 115:463-469.
25. Kozak C.A., Filie J., Adamson M.C., Chen Y., Yu L. Murine chromosomal location of the mu and kappa opioid receptor genes. Genomics 1994, 21:659-661.
26. Liu Q.R., Zhang P.W., Zhen Q., Walther D., Wang X.B., Uhl G.R. KEPI, a PKC-dependent protein phosphatase 1 inhibitor regulated by morphine. J Biol Chem 2002, 277:13312-13320.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
28. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., Wei L.N. Mu opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 1998, 54:321-326.
29. Lush I.E. The genetics of tasting in mice III. Quinine. Genet Res 1984, 44(2):151-160.
30. Mácsai M., Szabó G., Telegdy G. Vasoactive intestinal polypeptide induces analgesia and impairs the antinociceptive effect of morphine in mice. Neuropeptides 1998, 32:557-562.
31. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dollé P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996, 383:819-823.
32. Muraki T., Kato R. Genetic analysis of hypothermia induced by morphine in two strains of inbred mice. Pharmacol Biochem Behav 1987, 27:87-91.
33. Nelson T.M., Munger S.D., Boughter J.D. Haplotypes at the Tas2r locus on distal chromosome 6 vary with quinine taste sensitivity in inbred mice. BMC Genet 2005, 6:32-44.
34. Newrzella D., Pahlavan P.S., Krüger C., Boehm C., Sorgenfrei O., Schröck H., Eisenhardt G., Bischoff N., Vogt G., Wafzig O., Rossner M., Maurer M.H., Hiemisch H., Bach A., Kuschinsky W., Schneider A. The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia. BMC Genomics 2007, 8:370-387.
35. Orsini C., Bonito-Oliva A., Conversi D., Cabib S. Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL/6 and DBA/2 inbred strains. Psychopharmacology (Berl) 2005, 181:327-336.
36. Pan Y.X. Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 2005, 24:736-750.
37. Pasternak G.W. The pharmacology of mu analgesics: from patients to genes. Neuroscientist 2001, 7:220-231.
38. Rokita S.E., Adler J.M., McTamney P.M., Watson J.A. Efficient use and recycling of the micronutrient iodide in mammals. Biochimie 2010, 92:1227-1235.
39. Schuller A.G., King M.A., Zhang J., Bolan E., Pan Y.X., Morgan D.J., Chang A., Czick M.E., Unterwald E.M., Pasternak G.W., Pintar J.E. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci 1999, 2:151-156.
40. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A 1997, 94:1544-1549.
41. Suzuki T., Otani K., Misawa M. Differential sensitivity to physical dependence on morphine and codeine in three inbred strains of mice. Jpn J Pharmacol 1991, 57:455-462.
42. Szabó G., Mácsai M., Schek E., Telegdy G. The effect of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide on tolerance to morphine and alcohol in mice. Ann N Y Acad Sci 1998, 865:566-569.
43. Tapocik J.D., Letwin N., Mayo C.L., Frank B., Luu T., Achinike O., House C., Williams R., Elmer G.I., Lee N.H. Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine. J Neurosci 2009, 29:5295-5307.
44. Tian M., Broxmeyer H.E., Fan Y., Lai Z., Zhang S., Aronica S., Cooper S., Bigsby R.M., Steinmetz R., Engle S.J., Mestek A., Pollock J.D., Lehman M.N., Jansen H.T., Ying M., Stambrook P.J., Tischfield J.A., Yu L. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J Exp Med 1997, 185:1517-1522.
45. Weinert H., Masui H., Radichevich I., Werner S.C. Materials indistinguishable from iodotyrosines in normal human serum and human serum albumin. J Clin Invest 1967, 46:1264-1274.
46. Wellby M.L., O'Halloran M.W. The iodotyrosine content of normal human serum. Biochem J 1969, 112:543-544.
47. Wicker-Thomas C., Hamann M. Interaction of dopamine, female pheromones, locomotion and sex behavior in Drosophila melanogaster. J Insect Physiol 2008, 54:1423-1431.
48. Yang J., Wu J., Kowalska M.A., Dalvi A., Prevost N., O'Brien P.J., Manning D., Poncz M., Lucki I., Blendy J.A., Brass L.F. Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs. Proc Natl Acad Sci U S A 2000, 97:9984-9989.
49. Zhang H., Wang F., Kranzler H.R., Anton R.F., Gelernter J. Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. Behav Brain Funct 2012, 8:23-33.